Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Stock Holdings Decreased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lowered its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 0.7% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 253,001 shares of the real estate investment trust’s stock after selling 1,663 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Sabra Health Care REIT were worth $4,708,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Natixis bought a new stake in shares of Sabra Health Care REIT during the 1st quarter valued at about $633,000. Cetera Advisors LLC grew its position in shares of Sabra Health Care REIT by 996.2% during the 1st quarter. Cetera Advisors LLC now owns 149,574 shares of the real estate investment trust’s stock valued at $2,209,000 after buying an additional 135,929 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of Sabra Health Care REIT by 7.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 579,110 shares of the real estate investment trust’s stock valued at $8,918,000 after buying an additional 38,144 shares during the last quarter. Cetera Investment Advisers grew its position in shares of Sabra Health Care REIT by 34.1% during the 1st quarter. Cetera Investment Advisers now owns 406,675 shares of the real estate investment trust’s stock valued at $6,007,000 after buying an additional 103,413 shares during the last quarter. Finally, Renaissance Technologies LLC grew its position in shares of Sabra Health Care REIT by 77.0% during the 2nd quarter. Renaissance Technologies LLC now owns 1,287,279 shares of the real estate investment trust’s stock valued at $19,824,000 after buying an additional 559,800 shares during the last quarter. Institutional investors own 99.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the stock. Scotiabank boosted their price objective on shares of Sabra Health Care REIT from $17.00 to $18.00 and gave the company a “sector perform” rating in a research report on Friday, October 11th. Citigroup raised shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and boosted their target price for the company from $17.00 to $20.00 in a research note on Friday, September 13th. Wells Fargo & Company raised shares of Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and boosted their target price for the company from $16.00 to $20.00 in a research note on Tuesday, October 1st. Finally, Truist Financial boosted their target price on shares of Sabra Health Care REIT from $16.00 to $18.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $18.71.

Sabra Health Care REIT Trading Down 0.4 %

Shares of NASDAQ:SBRA opened at $18.11 on Tuesday. The company has a 50 day moving average of $18.61 and a 200-day moving average of $16.60. The firm has a market cap of $4.28 billion, a P/E ratio of 44.17, a P/E/G ratio of 2.28 and a beta of 1.25. Sabra Health Care REIT, Inc. has a twelve month low of $12.83 and a twelve month high of $20.03. The company has a current ratio of 4.16, a quick ratio of 4.16 and a debt-to-equity ratio of 0.90.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.35 by ($0.22). The company had revenue of $178.00 million during the quarter, compared to analyst estimates of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same period in the prior year, the company posted $0.34 earnings per share. As a group, analysts anticipate that Sabra Health Care REIT, Inc. will post 1.39 earnings per share for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Stockholders of record on Friday, November 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 6.63%. The ex-dividend date is Friday, November 15th. Sabra Health Care REIT’s dividend payout ratio is currently 292.68%.

About Sabra Health Care REIT

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.